De novo mutations in histone-modifying genes in congenital heart disease

Samir Zaidi, Murim Choi, Hiroko Wakimoto, Lijiang Ma, Jianming Jiang, John D. Overton, Angela Romano-Adesman, Robert D. Bjornson, Roger E. Breitbart, Kerry K. Brown, Nicholas J. Carriero, Yee Him Cheung, John Deanfield, Steve Depalma, Khalid Adnan Mohamed A. Fakhro, Joseph Glessner, Hakon Hakonarson, Michael J. Italia, Jonathan R. Kaltman, Juan Kaski & 30 others Richard Kim, Jennie K. Kline, Teresa Lee, Jeremy Leipzig, Alexander Lopez, Shrikant M. Mane, Laura E. Mitchell, Jane W. Newburger, Michael Parfenov, Itsik Pe'Er, George Porter, Amy E. Roberts, Ravi Sachidanandam, Stephan J. Sanders, Howard S. Seiden, Mathew W. State, Sailakshmi Subramanian, Irina R. Tikhonova, Wei Wang, Dorothy Warburton, Peter S. White, Ismee A. Williams, Hongyu Zhao, Jonathan G. Seidman, Martina Brueckner, Wendy K. Chung, Bruce D. Gelb, Elizabeth Goldmuntz, Christine E. Seidman, Richard P. Lifton

Research output: Contribution to journalArticle

420 Citations (Scopus)

Abstract

Congenital heart disease (CHD) is the most frequent birth defect, affecting 0.8% of live births. Many cases occur sporadically and impair reproductive fitness, suggesting a role for de novo mutations. Here we compare the incidence of de novo mutations in 362 severe CHD cases and 264 controls by analysing exome sequencing of parent-offspring trios. CHD cases show a significant excess of protein-altering de novo mutations in genes expressed in the developing heart, with an odds ratio of 7.5 for damaging (premature termination, frameshift, splice site) mutations. Similar odds ratios are seen across the main classes of severe CHD. We find a marked excess of de novo mutations in genes involved in the production, removal or reading of histone 3 lysine 4 (H3K4) methylation, or ubiquitination of H2BK120, which is required for H3K4 methylation. There are also two de novo mutations in SMAD2, which regulates H3K27 methylation in the embryonic left-right organizer. The combination of both activating (H3K4 methylation) and inactivating (H3K27 methylation) chromatin marks characterizes 'poised' promoters and enhancers, which regulate expression of key developmental genes. These findings implicate de novo point mutations in several hundreds of genes that collectively contribute to approximately 10% of severe CHD.

Original languageEnglish
Pages (from-to)220-223
Number of pages4
JournalNature
Volume498
Issue number7453
DOIs
Publication statusPublished - 2013
Externally publishedYes

Fingerprint

Histones
Heart Diseases
Methylation
Mutation
Genes
Odds Ratio
Genetic Fitness
Exome
Developmental Genes
Ubiquitination
Live Birth
Point Mutation
Lysine
Chromatin
Reading
Incidence
Proteins

ASJC Scopus subject areas

  • Medicine(all)
  • General

Cite this

Zaidi, S., Choi, M., Wakimoto, H., Ma, L., Jiang, J., Overton, J. D., ... Lifton, R. P. (2013). De novo mutations in histone-modifying genes in congenital heart disease. Nature, 498(7453), 220-223. https://doi.org/10.1038/nature12141

De novo mutations in histone-modifying genes in congenital heart disease. / Zaidi, Samir; Choi, Murim; Wakimoto, Hiroko; Ma, Lijiang; Jiang, Jianming; Overton, John D.; Romano-Adesman, Angela; Bjornson, Robert D.; Breitbart, Roger E.; Brown, Kerry K.; Carriero, Nicholas J.; Cheung, Yee Him; Deanfield, John; Depalma, Steve; Fakhro, Khalid Adnan Mohamed A.; Glessner, Joseph; Hakonarson, Hakon; Italia, Michael J.; Kaltman, Jonathan R.; Kaski, Juan; Kim, Richard; Kline, Jennie K.; Lee, Teresa; Leipzig, Jeremy; Lopez, Alexander; Mane, Shrikant M.; Mitchell, Laura E.; Newburger, Jane W.; Parfenov, Michael; Pe'Er, Itsik; Porter, George; Roberts, Amy E.; Sachidanandam, Ravi; Sanders, Stephan J.; Seiden, Howard S.; State, Mathew W.; Subramanian, Sailakshmi; Tikhonova, Irina R.; Wang, Wei; Warburton, Dorothy; White, Peter S.; Williams, Ismee A.; Zhao, Hongyu; Seidman, Jonathan G.; Brueckner, Martina; Chung, Wendy K.; Gelb, Bruce D.; Goldmuntz, Elizabeth; Seidman, Christine E.; Lifton, Richard P.

In: Nature, Vol. 498, No. 7453, 2013, p. 220-223.

Research output: Contribution to journalArticle

Zaidi, S, Choi, M, Wakimoto, H, Ma, L, Jiang, J, Overton, JD, Romano-Adesman, A, Bjornson, RD, Breitbart, RE, Brown, KK, Carriero, NJ, Cheung, YH, Deanfield, J, Depalma, S, Fakhro, KAMA, Glessner, J, Hakonarson, H, Italia, MJ, Kaltman, JR, Kaski, J, Kim, R, Kline, JK, Lee, T, Leipzig, J, Lopez, A, Mane, SM, Mitchell, LE, Newburger, JW, Parfenov, M, Pe'Er, I, Porter, G, Roberts, AE, Sachidanandam, R, Sanders, SJ, Seiden, HS, State, MW, Subramanian, S, Tikhonova, IR, Wang, W, Warburton, D, White, PS, Williams, IA, Zhao, H, Seidman, JG, Brueckner, M, Chung, WK, Gelb, BD, Goldmuntz, E, Seidman, CE & Lifton, RP 2013, 'De novo mutations in histone-modifying genes in congenital heart disease', Nature, vol. 498, no. 7453, pp. 220-223. https://doi.org/10.1038/nature12141
Zaidi S, Choi M, Wakimoto H, Ma L, Jiang J, Overton JD et al. De novo mutations in histone-modifying genes in congenital heart disease. Nature. 2013;498(7453):220-223. https://doi.org/10.1038/nature12141
Zaidi, Samir ; Choi, Murim ; Wakimoto, Hiroko ; Ma, Lijiang ; Jiang, Jianming ; Overton, John D. ; Romano-Adesman, Angela ; Bjornson, Robert D. ; Breitbart, Roger E. ; Brown, Kerry K. ; Carriero, Nicholas J. ; Cheung, Yee Him ; Deanfield, John ; Depalma, Steve ; Fakhro, Khalid Adnan Mohamed A. ; Glessner, Joseph ; Hakonarson, Hakon ; Italia, Michael J. ; Kaltman, Jonathan R. ; Kaski, Juan ; Kim, Richard ; Kline, Jennie K. ; Lee, Teresa ; Leipzig, Jeremy ; Lopez, Alexander ; Mane, Shrikant M. ; Mitchell, Laura E. ; Newburger, Jane W. ; Parfenov, Michael ; Pe'Er, Itsik ; Porter, George ; Roberts, Amy E. ; Sachidanandam, Ravi ; Sanders, Stephan J. ; Seiden, Howard S. ; State, Mathew W. ; Subramanian, Sailakshmi ; Tikhonova, Irina R. ; Wang, Wei ; Warburton, Dorothy ; White, Peter S. ; Williams, Ismee A. ; Zhao, Hongyu ; Seidman, Jonathan G. ; Brueckner, Martina ; Chung, Wendy K. ; Gelb, Bruce D. ; Goldmuntz, Elizabeth ; Seidman, Christine E. ; Lifton, Richard P. / De novo mutations in histone-modifying genes in congenital heart disease. In: Nature. 2013 ; Vol. 498, No. 7453. pp. 220-223.
@article{cfa7fc787bf347ce931c0ebac4c7ce76,
title = "De novo mutations in histone-modifying genes in congenital heart disease",
abstract = "Congenital heart disease (CHD) is the most frequent birth defect, affecting 0.8{\%} of live births. Many cases occur sporadically and impair reproductive fitness, suggesting a role for de novo mutations. Here we compare the incidence of de novo mutations in 362 severe CHD cases and 264 controls by analysing exome sequencing of parent-offspring trios. CHD cases show a significant excess of protein-altering de novo mutations in genes expressed in the developing heart, with an odds ratio of 7.5 for damaging (premature termination, frameshift, splice site) mutations. Similar odds ratios are seen across the main classes of severe CHD. We find a marked excess of de novo mutations in genes involved in the production, removal or reading of histone 3 lysine 4 (H3K4) methylation, or ubiquitination of H2BK120, which is required for H3K4 methylation. There are also two de novo mutations in SMAD2, which regulates H3K27 methylation in the embryonic left-right organizer. The combination of both activating (H3K4 methylation) and inactivating (H3K27 methylation) chromatin marks characterizes 'poised' promoters and enhancers, which regulate expression of key developmental genes. These findings implicate de novo point mutations in several hundreds of genes that collectively contribute to approximately 10{\%} of severe CHD.",
author = "Samir Zaidi and Murim Choi and Hiroko Wakimoto and Lijiang Ma and Jianming Jiang and Overton, {John D.} and Angela Romano-Adesman and Bjornson, {Robert D.} and Breitbart, {Roger E.} and Brown, {Kerry K.} and Carriero, {Nicholas J.} and Cheung, {Yee Him} and John Deanfield and Steve Depalma and Fakhro, {Khalid Adnan Mohamed A.} and Joseph Glessner and Hakon Hakonarson and Italia, {Michael J.} and Kaltman, {Jonathan R.} and Juan Kaski and Richard Kim and Kline, {Jennie K.} and Teresa Lee and Jeremy Leipzig and Alexander Lopez and Mane, {Shrikant M.} and Mitchell, {Laura E.} and Newburger, {Jane W.} and Michael Parfenov and Itsik Pe'Er and George Porter and Roberts, {Amy E.} and Ravi Sachidanandam and Sanders, {Stephan J.} and Seiden, {Howard S.} and State, {Mathew W.} and Sailakshmi Subramanian and Tikhonova, {Irina R.} and Wei Wang and Dorothy Warburton and White, {Peter S.} and Williams, {Ismee A.} and Hongyu Zhao and Seidman, {Jonathan G.} and Martina Brueckner and Chung, {Wendy K.} and Gelb, {Bruce D.} and Elizabeth Goldmuntz and Seidman, {Christine E.} and Lifton, {Richard P.}",
year = "2013",
doi = "10.1038/nature12141",
language = "English",
volume = "498",
pages = "220--223",
journal = "Nature",
issn = "0028-0836",
publisher = "Nature Publishing Group",
number = "7453",

}

TY - JOUR

T1 - De novo mutations in histone-modifying genes in congenital heart disease

AU - Zaidi, Samir

AU - Choi, Murim

AU - Wakimoto, Hiroko

AU - Ma, Lijiang

AU - Jiang, Jianming

AU - Overton, John D.

AU - Romano-Adesman, Angela

AU - Bjornson, Robert D.

AU - Breitbart, Roger E.

AU - Brown, Kerry K.

AU - Carriero, Nicholas J.

AU - Cheung, Yee Him

AU - Deanfield, John

AU - Depalma, Steve

AU - Fakhro, Khalid Adnan Mohamed A.

AU - Glessner, Joseph

AU - Hakonarson, Hakon

AU - Italia, Michael J.

AU - Kaltman, Jonathan R.

AU - Kaski, Juan

AU - Kim, Richard

AU - Kline, Jennie K.

AU - Lee, Teresa

AU - Leipzig, Jeremy

AU - Lopez, Alexander

AU - Mane, Shrikant M.

AU - Mitchell, Laura E.

AU - Newburger, Jane W.

AU - Parfenov, Michael

AU - Pe'Er, Itsik

AU - Porter, George

AU - Roberts, Amy E.

AU - Sachidanandam, Ravi

AU - Sanders, Stephan J.

AU - Seiden, Howard S.

AU - State, Mathew W.

AU - Subramanian, Sailakshmi

AU - Tikhonova, Irina R.

AU - Wang, Wei

AU - Warburton, Dorothy

AU - White, Peter S.

AU - Williams, Ismee A.

AU - Zhao, Hongyu

AU - Seidman, Jonathan G.

AU - Brueckner, Martina

AU - Chung, Wendy K.

AU - Gelb, Bruce D.

AU - Goldmuntz, Elizabeth

AU - Seidman, Christine E.

AU - Lifton, Richard P.

PY - 2013

Y1 - 2013

N2 - Congenital heart disease (CHD) is the most frequent birth defect, affecting 0.8% of live births. Many cases occur sporadically and impair reproductive fitness, suggesting a role for de novo mutations. Here we compare the incidence of de novo mutations in 362 severe CHD cases and 264 controls by analysing exome sequencing of parent-offspring trios. CHD cases show a significant excess of protein-altering de novo mutations in genes expressed in the developing heart, with an odds ratio of 7.5 for damaging (premature termination, frameshift, splice site) mutations. Similar odds ratios are seen across the main classes of severe CHD. We find a marked excess of de novo mutations in genes involved in the production, removal or reading of histone 3 lysine 4 (H3K4) methylation, or ubiquitination of H2BK120, which is required for H3K4 methylation. There are also two de novo mutations in SMAD2, which regulates H3K27 methylation in the embryonic left-right organizer. The combination of both activating (H3K4 methylation) and inactivating (H3K27 methylation) chromatin marks characterizes 'poised' promoters and enhancers, which regulate expression of key developmental genes. These findings implicate de novo point mutations in several hundreds of genes that collectively contribute to approximately 10% of severe CHD.

AB - Congenital heart disease (CHD) is the most frequent birth defect, affecting 0.8% of live births. Many cases occur sporadically and impair reproductive fitness, suggesting a role for de novo mutations. Here we compare the incidence of de novo mutations in 362 severe CHD cases and 264 controls by analysing exome sequencing of parent-offspring trios. CHD cases show a significant excess of protein-altering de novo mutations in genes expressed in the developing heart, with an odds ratio of 7.5 for damaging (premature termination, frameshift, splice site) mutations. Similar odds ratios are seen across the main classes of severe CHD. We find a marked excess of de novo mutations in genes involved in the production, removal or reading of histone 3 lysine 4 (H3K4) methylation, or ubiquitination of H2BK120, which is required for H3K4 methylation. There are also two de novo mutations in SMAD2, which regulates H3K27 methylation in the embryonic left-right organizer. The combination of both activating (H3K4 methylation) and inactivating (H3K27 methylation) chromatin marks characterizes 'poised' promoters and enhancers, which regulate expression of key developmental genes. These findings implicate de novo point mutations in several hundreds of genes that collectively contribute to approximately 10% of severe CHD.

UR - http://www.scopus.com/inward/record.url?scp=84879001958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879001958&partnerID=8YFLogxK

U2 - 10.1038/nature12141

DO - 10.1038/nature12141

M3 - Article

VL - 498

SP - 220

EP - 223

JO - Nature

JF - Nature

SN - 0028-0836

IS - 7453

ER -